Al-Eitan L, ElMotasem M, Khair I, Alahmad S
Curr Pharm Des. 2024; 30(13):1031-1047.
PMID: 38898820
DOI: 10.2174/0113816128280417231204085137.
Dumonteil E, Tu W, Desale H, Goff K, Marx P, Ortega-Lopez J
J Biomed Sci. 2024; 31(1):58.
PMID: 38824576
PMC: 11143712.
DOI: 10.1186/s12929-024-01050-5.
Naidoo L, Arumugam T, Ramsuran V
Infect Dis Rep. 2024; 16(2):380-406.
PMID: 38667755
PMC: 11049896.
DOI: 10.3390/idr16020029.
Tatarunas V, ciapiene I, Giedraitiene A
Pharmaceutics. 2024; 16(2).
PMID: 38399346
PMC: 10893373.
DOI: 10.3390/pharmaceutics16020292.
Dumonteil E, Tu W, Desale H, Goff K, Marx P, Ortega-Lopez J
Res Sq. 2023; .
PMID: 37961272
PMC: 10635379.
DOI: 10.21203/rs.3.rs-3453582/v1.
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations.
Purcell R, Theisen R, Arnold K, Chung A, Selva K
Front Immunol. 2023; 14:1183727.
PMID: 37600816
PMC: 10433199.
DOI: 10.3389/fimmu.2023.1183727.
Characterization of the expressed RNA variants from young patients with critical and non-critical SARS-CoV-2 infection.
Okendo J
Egypt J Med Hum Genet. 2023; 23(1):115.
PMID: 37521832
PMC: 9362069.
DOI: 10.1186/s43042-022-00327-4.
Vaccinomics: A scoping review.
Dudley M, Gerber J, Budigan Ni H, Blunt M, Holroyd T, Carleton B
Vaccine. 2023; 41(14):2357-2367.
PMID: 36803903
PMC: 10065969.
DOI: 10.1016/j.vaccine.2023.02.009.
An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines.
Bayani F, Hashkavaei N, Arjmand S, Rezaei S, Uskokovic V, Alijanianzadeh M
Prog Biophys Mol Biol. 2023; 178:32-49.
PMID: 36801471
PMC: 9938630.
DOI: 10.1016/j.pbiomolbio.2023.02.004.
Hesitant and anti-vaccination groups: A qualitative study on their perceptions and attitudes regarding vaccinations and their reluctance to participate in academic research- an example during a measles outbreak among a group of Jewish parents in....
Hijazi R, Gesser-Edelsburg A, Feder-Bubis P, Mesch G
Front Public Health. 2022; 10:1012822.
PMID: 36438238
PMC: 9682119.
DOI: 10.3389/fpubh.2022.1012822.
The rs1883832 Polymorphism (CD40-1C>T) Affects the Intensity of IgA Responses after BNT162b2 Vaccination.
Speletas M, Bakaros E, Peristeri A, Voulgaridi I, Sarrou S, Paliatsa V
Int J Mol Sci. 2022; 23(22).
PMID: 36430533
PMC: 9697403.
DOI: 10.3390/ijms232214056.
Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens.
Huang Y, Zhang Y, Seaton K, De Rosa S, Heptinstall J, Carpp L
EBioMedicine. 2022; 84:104271.
PMID: 36179551
PMC: 9520208.
DOI: 10.1016/j.ebiom.2022.104271.
The Correlation between Subolesin-Reactive Epitopes and Vaccine Efficacy.
Contreras M, Kasaija P, Kabi F, Mugerwa S, de la Fuente J
Vaccines (Basel). 2022; 10(8).
PMID: 36016215
PMC: 9414912.
DOI: 10.3390/vaccines10081327.
Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach.
Khan T, Khan A, Ansari J, Najmi M, Wei D, Muhammad K
Molecules. 2022; 27(7).
PMID: 35408772
PMC: 9000378.
DOI: 10.3390/molecules27072375.
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies.
Biswas M, Sawajan N, Rungrotmongkol T, Sanachai K, Ershadian M, Sukasem C
Front Pharmacol. 2022; 13:835136.
PMID: 35250581
PMC: 8894812.
DOI: 10.3389/fphar.2022.835136.
Single Nucleotide Polymorphisms in the Human Leukocyte Antigen Region Are Associated With Hemagglutination Inhibition Antibody Response to Influenza Vaccine.
Zhong S, Wei H, Li M, Cheng Y, Wen S, Wang D
Front Genet. 2022; 13:790914.
PMID: 35198005
PMC: 8859407.
DOI: 10.3389/fgene.2022.790914.
Determination Factors Associated with Immune Responses Towards First Dose Edmonston-Zagreb (EZ) Measles Vaccine in Indonesian Infants.
Teni Nurlatifah H, Barlianto W, Wiyasa W, Kusuma C, Sari T, Bachtiar N
Med Arch. 2022; 75(5):335-339.
PMID: 35169353
PMC: 8740659.
DOI: 10.5455/medarh.2021.75.335-339.
Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain.
Eto A, Yamamoto N, Kanatani Y
Biology (Basel). 2021; 10(11).
PMID: 34827150
PMC: 8614788.
DOI: 10.3390/biology10111158.
Early Pro-Inflammatory Signal and T-Cell Activation Associate With Vaccine-Induced Anti-Vaccinia Protective Neutralizing Antibodies.
Hou J, Wang S, Li D, Carpp L, Zhang T, Liu Y
Front Immunol. 2021; 12:737487.
PMID: 34707608
PMC: 8542877.
DOI: 10.3389/fimmu.2021.737487.
Poor CD4 T Cell Immunogenicity Limits Humoral Immunity to Transmission-Blocking Candidate Pfs25 in Humans.
Zaric M, Marini A, Nielsen C, Gupta G, Mekhaiel D, Pham T
Front Immunol. 2021; 12:732667.
PMID: 34659219
PMC: 8515144.
DOI: 10.3389/fimmu.2021.732667.